INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 19 filers reported holding INFLARX NV in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $116,000 | -36.6% | 80,000 | -20.0% | 0.09% | -50.3% |
| Q1 2022 | $183,000 | -61.6% | 100,000 | 0.0% | 0.17% | -32.2% |
| Q4 2021 | $476,000 | -42.2% | 100,000 | -68.6% | 0.26% | -33.2% |
| Q3 2021 | $823,000 | -19.2% | 318,000 | -7.3% | 0.38% | -5.9% |
| Q2 2021 | $1,018,000 | -25.4% | 343,000 | -2.0% | 0.41% | -20.2% |
| Q1 2021 | $1,365,000 | -22.4% | 350,000 | 0.0% | 0.51% | +6.0% |
| Q4 2020 | $1,760,000 | +18.0% | 350,000 | 0.0% | 0.48% | -23.8% |
| Q3 2020 | $1,491,000 | +54.8% | 350,000 | +66.7% | 0.63% | +12.3% |
| Q2 2020 | $963,000 | -31.8% | 210,000 | -43.2% | 0.56% | -47.8% |
| Q1 2020 | $1,413,000 | -28.6% | 370,000 | -26.0% | 1.08% | +75.1% |
| Q4 2019 | $1,980,000 | +60.3% | 500,000 | 0.0% | 0.61% | +62.4% |
| Q3 2019 | $1,235,000 | +39.7% | 500,000 | +78.6% | 0.38% | +44.8% |
| Q2 2019 | $884,000 | – | 280,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
| RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
| Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
| Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
| EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
| Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
| Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
| Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
| Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |